Skip to main content

Advertisement

SpringerLink
Log in

Screening for Colorectal Cancer: When, how, and by Whom?

  • Prevention and Early Detection (N Arber, Section Editor)
  • Published:
Current Colorectal Cancer Reports

Abstract

Screening the average-risk population is recommended to reduce CRC-related mortality. Several CRC screening tests are available, stool-based tests or structural endoscopic and radiologic examinations, all with their specific advantages and disadvantages. In this review, we discuss the screening test options for the average-risk population, when, how and by whom? We evaluate the growing body of evidence that support the implementation of FIT and endoscopic modalities in national screening programmes and we discuss the advances in newer screening tests.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Segnan N, Patnick J, von Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: Publications Office of the European Union; 2010. ISBN 978-92-79-16435-4 (printed version). Very extensive overview off all evidence of screening modalities and other aspects regarding screening including organization and quality issues in Europe

    Google Scholar 

  2. Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–89.

    Article  PubMed  Google Scholar 

  3. Wilson JM, Jungner YG. [Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam. 1968;65:281–393.

    PubMed  CAS  Google Scholar 

  4. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.

    Article  PubMed  Google Scholar 

  5. Heresbach D, Manfredi S, D’halluin PN, Bretagne JF, Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 2006;18(4):427–33.

    Article  PubMed  Google Scholar 

  6. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135:82–90.

    Article  PubMed  Google Scholar 

  7. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100(7):1103–10.

    Article  PubMed  CAS  Google Scholar 

  8. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer. 2009;101(8):1274–81.

    Article  PubMed  Google Scholar 

  9. • de Wijkerslooth TR, Stoop EM, Bossuyt PM, Meijer GA, van Ballegooijen M, van Roon AH, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol. 2012;107(10):1570–8. Randomized controlled trial of the FIT performance in the proximal and distal colon in an average risk colonoscopy-controlled population.

    Article  PubMed  Google Scholar 

  10. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, Van Dekken H, Reijerink JC, et al. Screening for colorectal cancer; randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2009;59(1):62–8.

    Google Scholar 

  11. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351(26):2704–14.

    Article  PubMed  CAS  Google Scholar 

  12. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008;149(7):441–50.

    PubMed  Google Scholar 

  13. • Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012;142(2):248–56. Large case–control study in which a next-generation, promising stool DNA test is compared in a colonoscopy-controlled referral population.

    Article  PubMed  CAS  Google Scholar 

  14. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343(3):169–74.

    Article  PubMed  CAS  Google Scholar 

  15. Levin TR, Farraye FA, Schoen RE, Hoff G, Atkin W, Bond JH, et al. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005;54(6):807–13.

    Article  PubMed  CAS  Google Scholar 

  16. •• Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–33. The first large randomised controlled trial with more than 10 years of follow up in which it was shown that one-time flexible sigmoidoscopy reduces CRC incidence and mortality.

    Article  PubMed  Google Scholar 

  17. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ. 2009;338:b1846.

    Article  PubMed  Google Scholar 

  18. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, et al. Baseline findings of the Italian multicenter randomized controlled trial of ‘once-only sigmoidoscopy’–SCORE. J Natl Cancer Inst. 2002;94(23):1763–72.

    Article  PubMed  Google Scholar 

  19. Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132(7):2304–12.

    Article  PubMed  Google Scholar 

  20. •• Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62–8. Well performed randomized controlled trial comparing participation and detection rates of advanced neoplasia of three screening tests in a screening population.

    Article  PubMed  CAS  Google Scholar 

  21. Lewis JD, Ng K, Hung KE, Bilker WB, Berlin JA, Brensinger C, et al. Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med. 2003;163(4):413–20.

    Article  PubMed  Google Scholar 

  22. Betes IM, Munoz-Navas MA, Duque JM, Angos R, Macias E, Subtil JC, et al. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy. Gastrointest Endosc. 2004;59(6):634–41.

    Article  Google Scholar 

  23. •• Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345–57. The third large randomised controlled trial with more than 10 years of follow up in which it was shown that one-time flexible sigmoidoscopy reduces CRC incidence and mortality.

    Article  PubMed  CAS  Google Scholar 

  24. •• Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial–SCORE. J Natl Cancer Inst. 2011;103(17):1310–22. The second European large randomised controlled trial with more than 10 years of follow up in which it was shown that one-time flexible sigmoidoscopy reduces CRC incidence but not mortality.

    Article  PubMed  Google Scholar 

  25. Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc. 2002;55(3):307–14.

    Article  PubMed  Google Scholar 

  26. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355(18):1863–72.

    Article  PubMed  CAS  Google Scholar 

  27. •• Stoop EM, de Haan MC, de Wijkerslooth TR, Bossuyt PM, van Ballegooijen M, Nio CY, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 2012;13(1):55–64. The first randomized controlled trial comparing participation, test acceptability, and detection rates of CT colonography versus colonoscopy in a screening population.

    Article  PubMed  Google Scholar 

  28. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101(2):343–50.

    Article  PubMed  Google Scholar 

  29. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63(4 Suppl):S16–28.

    Article  PubMed  Google Scholar 

  30. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006;355(24):2533–41.

    Article  PubMed  CAS  Google Scholar 

  31. Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc. 2003;58(1):76–9.

    Article  PubMed  Google Scholar 

  32. Marmo R, Rotondano G, Riccio G, Marone A, Bianco MA, Stroppa I, et al. Effective bowel cleansing before colonoscopy: a randomized study of split-dosage versus non-split dosage regimens of high-volume versus low-volume polyethylene glycol solutions. Gastrointest Endosc. 2010;72(2):313–20.

    Article  PubMed  Google Scholar 

  33. Rex DK. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc. 2000;51(1):33–6.

    Article  PubMed  CAS  Google Scholar 

  34. Pox C, Schmiegel W, Classen M. Current status of screening colonoscopy in Europe and in the United States. Endoscopy. 2007;39(2):168–73.

    Article  PubMed  CAS  Google Scholar 

  35. Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7(7):770–5.

    Article  PubMed  Google Scholar 

  36. Baxter NN, Goldwasser MA, Paszat LF. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1–8.

    PubMed  Google Scholar 

  37. The Northern-European Initiative on Colorectal Cancer (NordICC). http://clinicaltrials.gov/ct2/show/NCT00883792 2009 Apr.

  38. Colorectal cancer screening in average-risk population: immunochemical fecal occult blood testing versus colonoscopy. http://www.clinicaltrials.gov/ct2/show/NCT00906997 2009 May.

  39. Eliakim R, Yassin K, Niv Y, Metzger Y, Lachter J, Gal E, et al. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy. Endoscopy. 2009;41(12):1026–31.

    Article  PubMed  CAS  Google Scholar 

  40. Kato J, Morikawa T, Kuriyama M, Yamaji Y, Wada R, Mitsushima T, et al. Combination of sigmoidoscopy and a fecal immunochemical test to detect proximal colon neoplasia. Clin Gastroenterol Hepatol. 2009;7(12):1341–6.

    Article  PubMed  Google Scholar 

  41. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2001;345(8):555–60.

    Article  PubMed  CAS  Google Scholar 

  42. Jensch S, de Vries AH, Peringa J, Bipat S, Dekker E, Baak LC, et al. CT colonography with limited bowel preparation: performance characteristics in an increased-risk population. Radiology. 2008;247(1):122–32.

    Article  PubMed  Google Scholar 

  43. Lefere PA, Gryspeerdt SS, Dewyspelaere J, Baekelandt M, van Holsbeeck BG. Dietary fecal tagging as a cleansing method before CT colonography: initial results polyp detection and patient acceptance. Radiology. 2002;224(2):393–403.

    Article  PubMed  Google Scholar 

  44. Burling D. CT colonography standards. Clin Radiol. 2010;65(6):474–80.

    Article  PubMed  CAS  Google Scholar 

  45. Kim DH, Pickhardt PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2007;357(14):1403–12.

    Article  PubMed  CAS  Google Scholar 

  46. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349(23):2191–200.

    Article  PubMed  CAS  Google Scholar 

  47. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008;359(12):1207–17.

    Article  PubMed  CAS  Google Scholar 

  48. van der Paardt MP, Zijta F, Stoker J. MRI of the colon. Imaging Med. 2010;2:195–209.

    Article  Google Scholar 

  49. Zijta FM, Bipat S, Stoker J. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies. Eur Radiol. 2010;20(5):1031–46.

    Article  PubMed  Google Scholar 

  50. Kuehle CA, Langhorst J, Ladd SC, Zoepf T, Nuefer M, Grabellus F, et al. Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population. Gut. 2007;56(8):1079–85.

    Article  PubMed  Google Scholar 

  51. Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, et al. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients’ participation. Am J Gastroenterol. 2010;105(1):188–98.

    Article  PubMed  Google Scholar 

  52. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003;10(3):117–22.

    Article  PubMed  CAS  Google Scholar 

  53. Zajac IT, Whibley AH, Cole SR, Byrne D, Guy J, Morcom J, et al. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. J Med Screen. 2010;17(1):19–24. Erratum in: J Med Screen. 2010 Jun;17(2):106.

    Article  PubMed  CAS  Google Scholar 

  54. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst. 2005;97(5):347–57.

    Article  PubMed  Google Scholar 

  55. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ. 2004;329(7458):133.

    Article  Google Scholar 

  56. Van Putten PG, Ter Borg F, Adang RP. Nurse endoscopists perform colonoscopies according to the international standard and with high patient satisfaction. Endoscopy 2012;44(12):1127–32.

    Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Gastroenterology and Hepatology, VU University Medical Centre, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands

    Jochim S. Terhaar sive Droste

  2. Department of Gastroenterology and Hepatology, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium

    Elisabeth Macken

  3. Department of Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium

    Jochim S. Terhaar sive Droste & Marc A. Peeters

Authors
  1. Jochim S. Terhaar sive Droste
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth Macken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc A. Peeters
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc A. Peeters.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terhaar sive Droste, J.S., Macken, E. & Peeters, M.A. Screening for Colorectal Cancer: When, how, and by Whom?. Curr Colorectal Cancer Rep 9, 17–23 (2013). https://doi.org/10.1007/s11888-012-0150-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-012-0150-5

Keywords

Search

Navigation